Cancer, a risk factor of hypersensitivity reaction to iodinated contrast media ?

Dellis, Perrine;Pirson, F
(2021) European Academy of Allergy and Clinical Immunology Hybrid Congress (10.July.2021)

Files

202176282AllergyEAACIabstractDellisCancerariskfactorofHTtoiodinatedcontrastmedia.docx
  • Open Access
  • Microsoft Word XML
  • 124.76 KB
Download

Details

Authors
  • Dellis, PerrineUCLouvain
    Author
  • Pirson, FUCLouvain
    Author
Abstract
Background: In our allergologial unit, it seemed that among patients evaluated for a suspicion of hypersensitivity (HS) to iodinated con-trast media (ICM), most of them were oncologic patients (just diag-nosed or with finished/ongoing treatment). Repeated exposures to ICM were previously described as a risk fac-tor of HS to ICM and they are frequent in the oncologic population Moreover, antineoplasic treatments as risk factors of HS reactions to ICM have been the topic of some studies, without clear conclusions at this time.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Dellis, P., & Pirson, F. (2021). Cancer, a risk factor of hypersensitivity reaction to iodinated contrast media ? ALLERGY, 76(S110), 282. https://hdl.handle.net/2078.5/165018 (Original work published 2021)